Skip to content

Drug interactions

Baricitinib + Tofacitinib

Severity: Contraindicated

Baricitinib and Tofacitinib: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Two JAK inhibitors given together provide duplicate immunosuppression with no established added benefit. The risk of serious infection and other JAK-related adverse effects increases.

What this interaction means in plain words

Baricitinib and Tofacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Baricitinib belongs to Musculoskeletal; Tofacitinib belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Duplicate JAK inhibition causing additive immunosuppression.

What to do

Do not use two JAK inhibitors together; select a single agent. If switching, stop one before starting the other.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Baricitinib and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Baricitinib with Tofacitinib?

MediHelp rates the interaction as contraindicated. Baricitinib and Tofacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Two JAK inhibitors given together provide duplicate immunosuppression with no established added benefit. The risk of serious infection and other JAK-related adverse effects increases.

How serious is the interaction between Baricitinib and Tofacitinib?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use two JAK inhibitors together; select a single agent. If switching, stop one before starting the other.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Cladribine, Upadacitinib, Abatacept. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in